Next Science Limited (NXS.AX)

0.2000 0.0000 (0.00%) At close: 03:56PM AEST

Next Science Limited

Australia Square
Level 14 264-278 George Street
Sydney, NSW 2000
Australia
61 4 1229 2977
https://www.nextscience.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Harry Thomas Hall	MD, CEO & Director	616.39k	N/A	N/A
Dr. Matthew Franco Myntti	Founder & CTO	542.91k	N/A	N/A
Marc Zimmerman	Chief Financial Officer	505.83k	N/A	N/A
Mr. Jon Swanson	Chief Operating Officer	390.96k	N/A	N/A
Mr. Robert Bell	Senior Vice President of North American Sales	N/A	N/A	N/A
Ms. Gillian Maria Nairn AGIA, B.A., BA, L.L.B., L.L.M., LLB, LLM, MAICD	Company Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Next Science Limited engages in the research, development, and commercialization of technologies that address the issues in human health caused by biofilms, incumbent bacteria, fungus, viruses, and infections in North America, Australia, and New Zealand. It offers SURGX, an antimicrobial gel that conforms to the postoperative wound; BACTISURE wound lavage; BlastX, an antimicrobial wound gel that provides wound management by maintaining a moist wound environment, which is conducive to wound healing; and XPERIENCE for use in cleansing and removal of debris, including microorganisms from wounds. The company was founded in 2012 and is headquartered in Sydney, Australia.

Corporate governance

Next Science Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.